Medigene AG (FRA:MDG1) Total Stockholders Equity : €21.07 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Medigene AG Total Stockholders Equity?

Medigene AG's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €21.07 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Medigene AG's Book Value per Share for the quarter that ended in Dec. 2023 was €0.81. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Medigene AG's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.14.

Medigene AG Total Stockholders Equity Historical Data

The historical data trend for Medigene AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigene AG Total Stockholders Equity Chart

Medigene AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

81.82

53.15

44.82

37.03

21.07

Medigene AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															44.82	59.14	37.03	30.19	21.07

Medigene AG (FRA:MDG1) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Medigene AG's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(21.067	-	0)	/	25.866
	=	0.81

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Medigene AG's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.914	+	2.036)	/	21.067
	=	0.14

Medigene AG Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Medigene AG's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Medigene AG (FRA:MDG1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (FRA:MDG1) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

0QGJ:UK MDG1:Germany MDG1:Austria

Address

Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152

Website

https://www.medigene.com

Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.

Medigene AG (FRA:MDG1) Headlines

No Headlines